TY - JOUR
T1 - Fabrication of dissolving microneedles for transdermal delivery of protein and peptide drugs
T2 - polymer materials and solvent casting micromoulding method
AU - Andranilla, Rr Kirana
AU - Anjani, Qonita Kurnia
AU - Hartrianti, Pietradewi
AU - Donnelly, Ryan F.
AU - Ramadon, Delly
N1 - Publisher Copyright:
© 2023 Informa UK Limited, trading as Taylor & Francis Group.
PY - 2023
Y1 - 2023
N2 - Proteins and peptides are rapidly developing pharmaceutical products and are expected to continue growing in the future. However, due to their nature, their delivery is often limited to injection, with drawbacks such as pain and needle waste. To overcome these limitations, microneedles technology is developed to deliver protein and peptide drugs through the skin. One type of microneedles, known as dissolving microneedles, has been extensively studied for delivering various proteins and peptides, including ovalbumin, insulin, bovine serum albumin, polymyxin B, vancomycin, and bevacizumab. This article discusses polymer materials used for fabricating dissolving microneedles, which are poly(vinylpyrrolidone), hyaluronic acid, poly(vinyl alcohol), carboxymethylcellulose, GantrezTM, as well as other biopolymers like pullulan and ulvan. The paper is focused solely on solvent casting micromoulding method for fabricating dissolving microneedles containing proteins and peptides, which will be divided into one-step and two-step casting micromoulding. Additionally, future considerations in the market plan for dissolving microneedles are discussed in this article.
AB - Proteins and peptides are rapidly developing pharmaceutical products and are expected to continue growing in the future. However, due to their nature, their delivery is often limited to injection, with drawbacks such as pain and needle waste. To overcome these limitations, microneedles technology is developed to deliver protein and peptide drugs through the skin. One type of microneedles, known as dissolving microneedles, has been extensively studied for delivering various proteins and peptides, including ovalbumin, insulin, bovine serum albumin, polymyxin B, vancomycin, and bevacizumab. This article discusses polymer materials used for fabricating dissolving microneedles, which are poly(vinylpyrrolidone), hyaluronic acid, poly(vinyl alcohol), carboxymethylcellulose, GantrezTM, as well as other biopolymers like pullulan and ulvan. The paper is focused solely on solvent casting micromoulding method for fabricating dissolving microneedles containing proteins and peptides, which will be divided into one-step and two-step casting micromoulding. Additionally, future considerations in the market plan for dissolving microneedles are discussed in this article.
KW - Dissolving microneedles
KW - micromoulding
KW - polymer materials
KW - proteins and peptides
KW - transdermal drug delivery
UR - http://www.scopus.com/inward/record.url?scp=85178075139&partnerID=8YFLogxK
U2 - 10.1080/10837450.2023.2285498
DO - 10.1080/10837450.2023.2285498
M3 - Review article
C2 - 37987717
AN - SCOPUS:85178075139
SN - 1083-7450
VL - 28
SP - 1016
EP - 1031
JO - Pharmaceutical Development and Technology
JF - Pharmaceutical Development and Technology
IS - 10
ER -